Priority Date: 16.06.16 (EP 20160174715)

BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS

  • Application ID: EP17732059
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Janssen Pharmaceutica N.V. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 225 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 16.06.2016 - Priority Date (EP 20160174715)
  • 21.12.2017 - Publication A1 (WO2017216292)
  • 24.04.2019 - Publication A1 (EP3472160)